WHO ICTRP trial
A study in multiple centres investigating the effect of two different active…
EUCTR2010-023104-28-NL · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-023104-28-NL |
|---|---|
| Public title | A study in multiple centres investigating the effect of two different active treatments for raised bloodpressure in elderly patients where it is unknown during the study which of both treatments is administered. |
| Scientific title | A multicentre randomised, double blind, active controlled, parallel group comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the treatment of isolated systolic hypertension in elderly patients. - The NEHIS Study |
| Primary sponsor | Menarini International Operations Luxembourg S.A. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Belgium;Netherlands |
| Conditions | Isolated Systolic Hypertension MedDRA version: 14.0 Level: LLT Classification code 10050591 Term: Isolated systolic hypertension System Organ Class: 10047065 - Vascular disorders ;Therapeutic area: Diseases [C] - Cardiovascular Diseases… |
| Interventions | Trade Name: Nebilet Plus Pharmaceutical Form: Capsule CAS Number: 152520-56-4 Other descriptive name: NEBIVOLOL HYDROCHLORIDE Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 5- INN or Proposed INN… |
| Registration date | Jun 29, 2011 |
| Target size | 150 |
| Secondary IDs | MEIN/10/Neb+HCTZ-Hyp/001 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: